Company Overview


Shaping the Future of In-silico Drug Design

PharmCADD, founded in 2019, is the leading in-silico drug design company committed to accelerating the path for discovering and developing de-novo therapeutics for diseases more efficiently.
Utilizing state-of-the-art technologies of deep neural networks, molecular dynamics simulation, quantum calculation and network theory,  Pharmulator™, our innovative artificial intelligence (AI)-based drug discovery platform, is poised to help global scientists tackle the most demanding challenges across the whole spectrum of drug discovery process.
PharmCADD, we relentlessly work hard to become a reliable navigator and partner for drug discovery.